Fight against cancer around the Mediterranean area: "Many hands make light work!".
暂无分享,去创建一个
[1] J. Daoud,et al. Nasopharyngeal cancer (NPC) around the Mediterranean area: standard of care. , 2012, Critical reviews in oncology/hematology.
[2] Arome. Guidelines, minimal requirements and standard of cancer care around the Mediterranean Area: report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties. , 2011, Critical reviews in oncology/hematology.
[3] P. Levine,et al. Inflammatory breast cancer in Tunisia , 2010, Cancer.
[4] A. Ghorbel,et al. Le carcinome nasopharyngé en Afrique du Nord et dans le Sud-Est asiatique : entre similitude et différence , 2010 .
[5] S. Rosso,et al. New data tells us more about cancer incidence in North Africa. , 2010, European journal of cancer.
[6] R. Zanetti,et al. [What are we learning from the new data on cancer incidence in North Africa]. , 2010, Epidemiologia & Prevenzione.
[7] M. Hsairi,et al. [Breast cancer in Tunisia: epidemiologic characteristics and trends in incidence]. , 2009, La Tunisie medicale.
[8] S. Remadi,et al. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients. , 2009, Archives of medical research.
[9] J. Zell,et al. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry , 2009, Breast Cancer Research.
[10] F. de Longueville,et al. Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. , 2008, Cancer genomics & proteomics.
[11] Bernard Rachet,et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.
[12] Y. Bignon,et al. BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases , 2008, International journal of medical sciences.
[13] T. Messai,et al. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. , 2008, Bulletin du cancer.
[14] H. Boussen,et al. Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. , 2008, Seminars in oncology.
[15] A. Benider,et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries , 2007, International journal of cancer.
[16] Wh Sit,et al. Cancer Genomics & Proteomics , 2007 .
[17] A. Ben Abdelaziz,et al. [Bibliometric profile of Tunisians medicals publications indexed in Medline from 2000 to 2003 part 2: social relevance]. , 2007, La Tunisie medicale.
[18] H. Adami,et al. The Enigmatic Epidemiology of Nasopharyngeal Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.
[19] S. Devesa,et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. , 2005, Journal of the National Cancer Institute.
[20] S. Tucker,et al. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center. , 2005, International journal of radiation oncology, biology, physics.
[21] N. Toumi,et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. , 2003, European journal of cancer.
[22] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[23] P. Levine,et al. Epidemiologic features of rapidly progressing breast cancer in Tunisia , 1980, Cancer.